Giordano Christopher Thomas
CEO
Giordano Christopher Thomas has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Sep 16, 2026.
On the most recent filing, Giordano Christopher Thomas is listed as CEO at TENAX THERAPEUTICS, INC. Inside the rolling window, Giordano Christopher Thomas reported 5 open-market purchases totaling $40K in TENX and no open-market sales. The largest disclosed transaction in the window is a purchase of 1,612 TENX shares on Nov 18, 2025, worth $13K.
Companies traded
Other insiders at TENX
Insider Buying
$40K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Giordano Christopher Thomas made?
Giordano Christopher Thomas has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Giordano Christopher Thomas trade?
Giordano Christopher Thomas has filed SEC Form 4 disclosures for 1 company, including TENX.
When was Giordano Christopher Thomas's most recent SEC Form 4 filing?
Giordano Christopher Thomas's most recent SEC Form 4 filing on Tracefour is dated Sep 16, 2026.
What is Giordano Christopher Thomas's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Giordano Christopher Thomas is listed as CEO.
What is Giordano Christopher Thomas's total buy and sell value in the current window?
Inside the rolling retention window, Giordano Christopher Thomas bought $40K and sold $0 based on SEC Form 4 filings.
What was Giordano Christopher Thomas's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,612 TENX shares on 2025-11-18, worth $13K, per SEC Form 4 filings.